Thyroid surgery: FLUOPTICS© reduces the risk of complications

Categorie(s) : Industry, Innovation & Society, News

Published : 3 February 2020

FLUOPTICS©, located in the High-tech Building (BHT), is getting encouraging feedback on its FLUOBEAM®LX imaging system for thyroid surgery. The system allows surgeons to clearly identify the four tiny parathyroid glands adjacent to the thyroid at the start of the surgery. This reduces the risk of accidental injury to or removal of the parathyroid glands, a complication that can have very serious consequences.

FLUOBEAM®LX uses a specific excitation wavelength that causes the parathyroid glands to emit autofluorescence without the need for a contrast medium. The light signal emitted is detected by a high-sensitivity camera. FLUOPTICS© is the first company in the world to offer this kind of imaging system and has obtained EU and US approvals for the system. At end-2019 the company had installed seventeen of its machines at top-named surgical practices in Europe and the US.




More information